BIAF (bioAffinity Technologies) Interest Expense: $-0.04 Mil (TTM As of Mar. 2026)

What is bioAffinity Technologies Interest Expense?

bioAffinity Technologies BIAF -1.48% 44 Interest Expense is $-0.04 Mil as of Mar. 2026. GuruFocus rates BIAF with a GF Score™ of 44/100 and a GF Value™ of $4.27 (Possible Value Trap). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. bioAffinity Technologies's interest expense for the three months ended in Mar. 2026 was $ -0.02 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.04 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. bioAffinity Technologies's Operating Income for the three months ended in Mar. 2026 was $ -3.62 Mil. bioAffinity Technologies's Interest Expense for the three months ended in Mar. 2026 was $ -0.02 Mil. bioAffinity Technologies did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

bioAffinity Technologies (NAS:BIAF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

bioAffinity Technologies's Interest Expense for the three months ended in Mar. 2026 was $-0.02 Mil. Its Operating Income for the three months ended in Mar. 2026 was $-3.62 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was $1.10 Mil.

bioAffinity Technologies's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

bioAffinity Technologies did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

bioAffinity Technologies Interest Expense Historical Data

* Premium members only.

The historical data trend for bioAffinity Technologies's Interest Expense can be seen below:

bioAffinity Technologies Interest Expense Chart

bioAffinity Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-1.00

-2.53

-0.04

-0.09

-0.04

bioAffinity Technologies Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-0.02	-0.01	-0.01	-0.01	-0.02

44GF Score

bioAffinity Technologies Inc BIAF

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

bioAffinity Technologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.04 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of $-0.04 Mil mean?

bioAffinity Technologies (BIAF) has a Interest Expense of $-0.04 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on bioAffinity Technologies and its competitors.

Is bioAffinity Technologies' Interest Expense too high?

bioAffinity Technologies' current Interest Expense is $-0.04 Mil. Overall, bioAffinity Technologies has a GF Score™ of 44/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does bioAffinity Technologies' Interest Expense compare to NDRA and ISPC?

bioAffinity Technologies' Interest Expense of $-0.04 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Medical Diagnostics & Research company?

A good Interest Expense depends on the Medical Diagnostics & Research industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on bioAffinity Technologies and its competitors. bioAffinity Technologies's current Interest Expense is $-0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is bioAffinity Technologies stock overvalued right now?

Based on GuruFocus' analysis, bioAffinity Technologies (BIAF) is currently considered Possible Value Trap. The stock's GF Value™ is $4.27, compared to a current price of $0.76 — trading 82.2% below its estimated fair value. The current Interest Expense is $-0.04 Mil. bioAffinity Technologies' overall GF Score™ is 44/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For bioAffinity Technologies (BIAF), the current Interest Expense is $-0.04 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is bioAffinity Technologies (BIAF) Overvalued in 2026?

Based on GuruFocus' analysis, bioAffinity Technologies stock appears to be undervalued. The current stock price of $0.76 is trading 82.2% below its estimated GF Value™ of $4.27. GuruFocus considers bioAffinity Technologies to be Possible Value Trap.

Key valuation signals for BIAF:

Interest Expense: $-0.04 Mil
GF Value™: $4.27 vs. price of $0.76 (82.2% below fair value)
GF Score™: 44/100 with 3 warning signs

No single metric tells the full story. See the BIAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

bioAffinity Technologies Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies NDRA ISPC ADVB MBAI FUNI IVRO PRPH XWEL IDTA NSTM TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN

Address 3300 Nacogdoches Road, Suite 216, San Antonio, TX, USA, 78217

Website https://www.bioaffinitytech.com

bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.

44GF Score

Get the complete analysis for BIAF

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.76

Price

$4.27

GF Value

View BIAF Analysis

See Interest Expense data for all stocks →